FBP1 and neoplasm: further demonstrated that decreased FBP1 expression promotes tumor growth and resistance to ICIs in tumor-burdened mice with STAT3-PD-L1 over-expression, which provides a possible perspective for breaking therapeutic resistance to ICIs (91).